Mark W. Lingen to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications Mark W. Lingen has written about TOR Serine-Threonine Kinases.
Connection Strength
0.048
-
PTEN deficiency contributes to the development and progression of head and neck cancer. Neoplasia. 2013 May; 15(5):461-71.
Score: 0.026
-
Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin. Head Neck. 2011 Dec; 33(12):1774-82.
Score: 0.022